Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi T May

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
The American Journal of Cardiology|September 22, 2010
Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare populationJeffrey L Anderson, Heidi T May, Benjamin D Horne, et al.
The American Journal of Cardiology|June 6, 2013
Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery diseaseJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
Open Heart|December 20, 2018
Improving CHA<sub>2</sub>DS<sub>2</sub>-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillationKevin G Graves, Heidi T May, Kirk U Knowlton, et al.
The American Journal of Cardiology|April 15, 2019
Safety and Efficacy of Periprocedural Heparin Plus a Short-Term Infusion of Tirofiban Versus Bivalirudin Monotherapy in Patients Who Underwent Percutaneous Coronary Intervention (from the Intermountain Heart Institute STAIR Observational Registry)Joseph B Muhlestein, Ian S Hackett, Heidi T May, et al.
Journal of Cardiovascular Electrophysiology|September 14, 2019
Free thyroxine within the normal reference range predicts risk of atrial fibrillationJeffrey L Anderson, Victoria Jacobs, Heidi T May, et al.
The Journal of Invasive Cardiology|March 5, 2008
Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventionPeter J Casterella, James R Revenaugh, James L Burke, et al.
European Journal of Preventive Cardiology|October 21, 2015
The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart StudyHeidi T May, John R Nelson, Seth T Lirette, et al.
Journal of Cardiovascular Electrophysiology|March 11, 2025
Atrial Fibrillation as a Predictor of Age-Related Macular DegenerationKaden T Bunch, Heidi T May, Kirk U Knowlton, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 1, 2022
Intermittent fasting and changes in Galectin-3: A secondary analysis of a randomized controlled trial of disease-free subjectsBenjamin D Horne, Jeffrey L Anderson, Heidi T May, et al.
The American Journal of Cardiology|August 19, 2007
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptideHeidi T May, Benjamin D Horne, Wayne C Levy, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
The American Journal of Cardiology|September 22, 2010
Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare populationJeffrey L Anderson, Heidi T May, Benjamin D Horne, et al.
The American Journal of Cardiology|June 6, 2013
Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery diseaseJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
Open Heart|December 20, 2018
Improving CHA<sub>2</sub>DS<sub>2</sub>-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillationKevin G Graves, Heidi T May, Kirk U Knowlton, et al.
The American Journal of Cardiology|April 15, 2019
Safety and Efficacy of Periprocedural Heparin Plus a Short-Term Infusion of Tirofiban Versus Bivalirudin Monotherapy in Patients Who Underwent Percutaneous Coronary Intervention (from the Intermountain Heart Institute STAIR Observational Registry)Joseph B Muhlestein, Ian S Hackett, Heidi T May, et al.
Journal of Cardiovascular Electrophysiology|September 14, 2019
Free thyroxine within the normal reference range predicts risk of atrial fibrillationJeffrey L Anderson, Victoria Jacobs, Heidi T May, et al.
The Journal of Invasive Cardiology|March 5, 2008
Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventionPeter J Casterella, James R Revenaugh, James L Burke, et al.
European Journal of Preventive Cardiology|October 21, 2015
The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart StudyHeidi T May, John R Nelson, Seth T Lirette, et al.
Journal of Cardiovascular Electrophysiology|March 11, 2025
Atrial Fibrillation as a Predictor of Age-Related Macular DegenerationKaden T Bunch, Heidi T May, Kirk U Knowlton, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 1, 2022
Intermittent fasting and changes in Galectin-3: A secondary analysis of a randomized controlled trial of disease-free subjectsBenjamin D Horne, Jeffrey L Anderson, Heidi T May, et al.
The American Journal of Cardiology|August 19, 2007
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptideHeidi T May, Benjamin D Horne, Wayne C Levy, et al.
Pageof 16